Low hemoglobin deferral in blood donors

Transfusion Medicine Reviews

Volumn 28, Issue 1, 2014, Pages 18-22

  Mast, Alan E ^a,b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ANEMIA, IRON-DEFICIENCY; BLOOD DONORS; BLOOD SAFETY; CAPILLARIES; DONOR SELECTION; ERYTHROPOIESIS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FERRITINS; HEALTH PROMOTION; HEMOGLOBINOMETRY; HEMOGLOBINS; HUMANS; IRON; MALE; NEOPLASMS, UNKNOWN PRIMARY; PREGNANCY; PREMENOPAUSE; REPRODUCIBILITY OF RESULTS; RISK; SEX CHARACTERISTICS; TIME FACTORS;

EID: 84893978343     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2013.11.001     Document Type: Review

References (58)

1. Beutler E., Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?. Blood 2006, 107:1747-1750.
2. Mast A.E., Schlumpf K.S., Wright D.J., Custer B., Spencer B., Murphy E.L., et al. Demographic correlates of low hemoglobin deferral among prospective whole blood donors. Transfusion 2010, 50:1794-1802.
3. Tong E., Murphy W.G., Kinsella A., Darragh E., Woods J., Murphy C., et al. Capillary and venous haemoglobin levels in blood donors: a 42-month study of 36,258 paired samples. Vox Sang 2010, 98:547-553.
4. Ziemann M., Lizardo B., Geusendam G., Schlenke P. Reliability of capillary hemoglobin screening under routine conditions. Transfusion 2011, 51:2714-2719.
5. Cable R.G., Steele W.R., Melmed R.S., Johnson B., Mast A.E., Carey P.M., et al. The difference between fingerstick and venous hemoglobin and hematocrit varies by sex and iron stores. Transfusion 2012, 52:1031-1040.
6. Bryant B.J., Yau Y.Y., Arceo S.M., Niel-Johnson J., Hopkins J.A., Leitman S.F. Iron replacement therapy in the routine management of blood donors. Transfusion 2012, 52:1566-1575.
7. Finch C.A., Cook J.D., Labbe R.F., Culala M. Effect of blood donation on iron stores as evaluated by serum ferritin. Blood 1977, 50:441-447.
8. Simon T.L., Garry P.J., Hooper E.M. Iron stores in blood donors. JAMA 1981, 245:2038-2043.
9. Cable R.G., Glynn S.A., Kiss J.E., Mast A.E., Steele W.R., Murphy E.L., et al. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2011, 51:511-522.
10. Delaney M., Schellhase K.G., Young S., Geiger S., Fink A., Mast A.E. Blood center practice and education for blood donors with anemia. Transfusion 2011, 51:929-936.
11. Vanzetti G. An azide-methemoglobin method for hemoglobin determination in blood. J Lab Clin Med 1966, 67:116-126.
12. Hillgrove T., Moore V., Doherty K., Ryan P. The impact of temporary deferral due to low hemoglobin: future return, time to return, and frequency of subsequent donation. Transfusion 2011, 51:539-547.
13. Garry P.J., Koehler K.M., Simon T.L. Iron stores and iron absorption: effects of repeated blood donations. Am J Clin Nutr 1995, 62:611-620.
14. Mast A.E., Foster T.M., Pinder H.L., Beczkiewicz C.A., Bellissimo D.B., Murphy A.T., et al. Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors. Transfusion 2008, 48:2197-2204.
15. Mast A.E., Steele W.R., Johnson B., Wright D.J., Cable R.G., Carey P., et al. Population-based screening for anemia using first-time blood donors. Am J Hematol 2012, 87:496-502.
16. Cable R.G., Glynn S.A., Kiss J.E., Mast A.E., Steele W.R., Murphy E.L., et al. Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2012, 52:702-711.
17. Mast A.E., Lee T.H., Schlumpf K.S., Wright D.J., Johnson B., Carrick D.M., et al. The impact of HFE mutations on haemoglobin and iron status in individuals experiencing repeated iron loss through blood donation. Br J Haematol 2012, 156:388-401.
18. Boulton, Collis, Inskip, Paes, Garlick A study of the iron and HFE status of blood donors, including a group who failed the initial screen for anaemia. Br J Haematol 2000, 108:434-439.
19. Baart A.M., de Kort W.L., Moons K.G., Vergouwe Y. Prediction of low haemoglobin levels in whole blood donors. Vox Sang 2011, 100:204-211.
20. Stern M., O'Meara A., Infanti L., Sigle J.P., Buser A. Prognostic value of red blood cell parameters and ferritin in predicting deferral due to low hemoglobin in whole blood donors. Ann Hematol 2012, 91:775-780.
21. Pasricha S.R., McQuilten Z.K., Keller A.J., Wood E.M. Hemoglobin and iron indices in nonanemic premenopausal blood donors predict future deferral from whole blood donation. Transfusion 2011, 51:2709-2713.
22. Radtke H., Meyer T., Kalus U., Rocker L., Salama A., Kiesewetter H., et al. Rapid identification of iron deficiency in blood donors with red cell indexes provided by Advia 120. Transfusion 2005, 45:5-10.
23. Semmelrock M.J., Raggam R.B., Amrein K., Avian A., Schallmoser K., Lanzer G., et al. Reticulocyte hemoglobin content allows early and reliable detection of functional iron deficiency in blood donors. Clin Chim Acta 2012, 413:678-682.
24. Kiss J.E., Steele W.R., Wright D.J., Mast A.E., Carey P.M., Murphy E.L., et al. Laboratory variables for assessing iron deficiency in REDS-II Iron Status Evaluation (RISE) blood donors. Transfusion 2013, 53:2766-2775.
25. Baart A.M., de Kort W.L., Moons K.G., Atsma F., Vergouwe Y. Zinc protoporphyrin levels have added value in the prediction of low hemoglobin deferral in whole blood donors. Transfusion 2013, 53:1661-1669.
26. Mast A.E., Schlumpf K.S., Wright D.J., Johnson B., Glynn S.A., Busch M.P., et al. Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy. Haematologica 2013, 98:1324-1330.
27. Nasserinejad K., de Kort W., Baart M., Komarek A., van Rosmalen J., Lesaffre E. Predicting hemoglobin levels in whole blood donors using transition models and mixed effects models. BMC Med Res Methodol 2013, 13:62.
28. Baart A.M., de Kort W.L., Atsma F., Moons K.G., Vergouwe Y. Development and validation of a prediction model for low hemoglobin deferral in a large cohort of whole blood donors. Transfusion 2012, 52:2559-2569.
29. Baart A.M., Atsma F., McSweeney E.N., Moons K.G., Vergouwe Y., de Kort W.L. External validation and updating of a Dutch prediction model for low hemoglobin deferral in Irish whole blood donors. Transfusion 2013, 10.1111/trf.12211.
30. Ganz T., Olbina G., Girelli D., Nemeth E., Westerman M. Immunoassay for human serum hepcidin. Blood 2008, 112:4292-4297.
31. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., et al. From the cover: lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. PNAS 2001, 98:8780-8785.
32. Ganz T., Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta 1823, 2012:1434-1443.
33. Finberg K.E. Iron-refractory iron deficiency anemia. Semin Hematol 2009, 46:378-386.
34. Pasricha S.R., Frazer D.M., Bowden D.K., Anderson G.J. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with beta-thalassemia major: a longitudinal study. Blood 2013, 122:124-133.
35. Pak M., Lopez M.A., Gabayan V., Ganz T., Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006, 108:3730-3735.
36. Edgren G., Bagnardi V., Bellocco R., Hjalgrim H., Rostgaard K., Melbye M., et al. Pattern of declining hemoglobin concentration before cancer diagnosis. Int J Cancer 2010, 127:1429-1436.
37. Young S., Fink A., Geiger S., Marbella A., Mast A.E., Schellhase K.G. Community blood donors' knowledge of anemia and design of a literacy-appropriate educational intervention. Transfusion 2010, 50:75-79.
38. Bryant B.J., Yau Y.Y., Arceo S.M., Hopkins J.A., Leitman S.F. Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome. Transfusion 2013, 53:1637-1644.
39. Spencer B.R., Kleinman S., Wright D.J., Glynn S.A., Rye D.B., Kiss J.E., et al. Restless legs syndrome, pica, and iron status in blood donors. Transfusion 2013, 53:1645-1652.
40. Silber M.H., Richardson J.W. Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clin Proc 2003, 78:52-54.
41. Newman B. Iron depletion by whole-blood donation harms menstruating females: the current whole-blood-collection paradigm needs to be changed. Transfusion 2006, 46:1667-1681.
42. Beutler E., Larsh S.E., Gurney C.W. Iron therapy in chronically fatigued, nonanemic women: a double-blind study. Ann Intern Med 1960, 52:378-394.
43. Krayenbuehl P.A., Battegay E., Breymann C., Furrer J., Schulthess G. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood 2011, 118:3222-3227.
44. Brownlie T., Utermohlen V., Hinton P.S., Haas J.D. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 2004, 79:437-443.
45. Scholl T.O., Hediger M.L., Fischer R.L., Shearer J.W. Anemia vs iron deficiency: increased risk of preterm delivery in a prospective study. Am J Clin Nutr 1992, 55:985-988.
46. Murray-Kolb L.E., Beard J.L. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 2007, 85:778-787.
47. Bruner A.B., Joffe A., Duggan A.K., Casella J.F., Brandt J. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 1996, 348:992-996.
48. Gogtay N., Giedd J.N., Lusk L., Hayashi K.M., Greenstein D., Vaituzis A.C., et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 2004, 101:8174-8179.
49. Jahanshad N., Kohannim O., Hibar D.P., Stein J.L., McMahon K.L., de Zubicaray G.I., et al. Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene. Proc Natl Acad Sci U S A 2012, 109:E851-E859.
50. Lieden G. Iron supplement to blood donors. I. Trials with intermittent iron supply. Acta Med Scand 1975, 197:31-36.
51. Simon T.L., Hunt W.C., Garry P.J. Iron supplementation for menstruating female blood donors. Transfusion 1984, 24:469-472.
52. Radtke H., Tegtmeier J., Rocker L., Salama A., Kiesewetter H. Daily doses of 20 mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study. Transfusion 2004, 44:1427-1432.
53. Gordeuk V.R., Brittenham G.M., Bravo J., Hughes M.A., Keating L.J. Prevention of iron deficiency with carbonyl iron in female blood donors. Transfusion 1990, 30:239-245.
54. Magnussen K., Bork N., Asmussen L. The effect of a standardized protocol for iron supplementation to blood donors low in hemoglobin concentration. Transfusion 2008, 48:749-754.
55. Bianco C., Brittenham G., Gilcher R.O., Gordeuk V.R., Kushner J.P., Sayers M., et al. Maintaining iron balance in women blood donors of childbearing age: summary of a workshop. Transfusion 2002, 42:798-805.
56. Mast A.E., Blinder M.A., Gronowski A.M., Chumley C., Scott M.G. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998, 44:45-51.
57. Radtke H., Polat G., Kalus U., Salama A., Kiesewetter H. Hemoglobin screening in prospective blood donors: comparison of different blood samples and different quantitative methods. Transfus Apher Sci 2005, 33:31-35.
58. O'Meara A., Infanti L., Stebler C., Ruesch M., Sigle J.P., Stern M., et al. The value of routine ferritin measurement in blood donors. Transfusion 2011, 51:2183-2188.